United States · Bill · HR
H.R. 1294 (105th)
To amend title 10, United States Code, to require the Secretary of Defense to provide to members of the Armed Forces who receive an investigational new drug relevant information regarding the drug, including the possible side effects of the drug.
Introduced
10 April 1997
Last action
—
Status
See H.R.1119.
Sponsors
—
Subjects
Discovery layer
Source updated
6 June 2025
Summary
Amends provisions governing the Civilian Health and Medical Program of the Uniformed Services (CHAMPUS) to provide that, whenever the Secretary of Defense requests or requires a member of the armed forces to receive an investigational new drug, the Secretary shall provide such member a notice identifying such drug as an investigational new drug, giving the reasons why such drug is being administered and disclosing possible side effects. Requires such notice to be provided before such drug is administered, if practicable, but in no case no later than 30 days afterwards. Requires the Secretary to report to the Congress the reasons a form of notice other than written notice is used.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 10 April 1997
Introduced in House (PDF)
Introduced in House · EN · 10 April 1997
Introduced in House
summary · EN · 10 April 1997
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/105th-congress/house-bill/1294
- Open data entity: https://api.congress.gov/v3/bill/105/hr/1294